Publications in collaboration with researchers from Hospital Severo Ochoa (8)

2024

  1. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution

    Mycoses, Vol. 67, Núm. 3

2023

  1. Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates

    Clinical Microbiology and Infection, Vol. 29, Núm. 12, pp. 1604.e1-1604.e6

  2. Correction: Díaz-García et al. Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis. J. Fungi 2022, 8, 1228

    Journal of Fungi

  3. Non-Candida isolates from blood cultures and intra-abdominal samples: data derived from a multicentre prospective study conducted in Madrid

    Revista Espanola de Quimioterapia

  4. Trends in antifungal resistance in Candida from a multicenter study conducted in Madrid (CANDIMAD study): fluconazole-resistant C. parapsilosis spreading has gained traction in 2022

    Antimicrobial Agents and Chemotherapy, Vol. 67, Núm. 11

2022

  1. Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance and absence of Candida auris

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3102-3109

  2. Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis

    Journal of Fungi, Vol. 8, Núm. 11

  3. Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution

    Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 8